Gedeon Richter: Cariprazine shows effectiveness in the treatment of mental health disorders with combined substance use disorder
BUDAPEST, Hungary, April 8, 2025 /PRNewswire/ -- At the 33rd Annual Meeting of the European Psychiatric Association (EPA; 5-8th April, Madrid), new analyses of cariprazine studies were presented by Gedeon Richter Plc. The scientific posters showed that cariprazine seems to be an appropriate treatment option for a difficult-to-treat patient population, schizophrenia patients with multiple psychotic episodes and cannabis use disorder. Three further scientific posters were presented, and a joint ses...